Physician profile
Gary Dumontier
NPI 1437192481
$765.26
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $14.41 · 2021: $133 · 2022: $105 · 2023: $250 · 2024: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $361.52 | 2022-2024 | Ubrelvy, Qulipta |
| Medtronic, INC. | $76.81 | 2021-2023 | Inpen Smart Insulin Delivery System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.73 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $27.45 | 2021 | |
| Lilly USA, LLC | $26.38 | 2021 | |
| Sanofi-Aventis U.S. LLC | $26.17 | 2019-2024 | |
| Novo Nordisk INC | $25.41 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $23.32 | 2019 | |
| Abbott Laboratories | $19.59 | 2021 | |
| Nevro Corp. | $17.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.50 | 2023 | Farxiga |
| Amgen INC. | $16.45 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.92 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.69 | 2023 | Seglentis |
| Paratek Pharmaceuticals, INC. | $12.30 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.19 | 2019 | |
| Glaxosmithkline, LLC. | $11.76 | 2019 | |
| Esperion Therapeutics, INC. | $11.66 | 2021 | |
| Medtronic Minimed, INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Dumontier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.